Squarepoint
SLDB icon

Squarepoint’s Solid Biosciences SLDB Stock Holding History

Squarepoint’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-44,769
Closed -$322K – 4929
2026
Q1 		$322K Sell
44,769
-5,285
-11% -$34K ﹤0.01% 3651
2025
Q4 		$282K Buy
+50,054
New +$271K ﹤0.01% 3644
2025
Q2 		– Sell
-105,682
Closed -$391K – 5002
2025
Q1 		$391K Buy
+105,682
New +$452K ﹤0.01% 3517
2024
Q4 		– Sell
-12,463
Closed -$86.9K – 5458
2024
Q3 		$86.9K Sell
12,463
-4,926
-28% -$40K ﹤0.01% 3902
2024
Q2 		$98.6K Buy
+17,389
New +$156K ﹤0.01% 3802
2021
Q3 		– Sell
-888
Closed -$49K – 3381
2021
Q2 		$49K Sell
888
-4,725
-84% -$312K ﹤0.01% 3108
2021
Q1 		$466K Buy
+5,613
New +$621K ﹤0.01% 2077
2020
Q4 		– Sell
-807
Closed -$25K – 3229
2020
Q3 		$25K Buy
+807
New +$30.9K ﹤0.01% 2410
2020
Q1 		– Sell
-4,947
Closed -$330K – 2447
2019
Q4 		$330K Buy
+4,947
New +$546K ﹤0.01% 1992
2019
Q3 		– Sell
-873
Closed -$75K – 2646
2019
Q2 		$75K Buy
+873
New +$95.2K ﹤0.01% 2257
2019
Q1 		– Sell
-1,631
Closed -$656K – 2411
2018
Q4 		$656K Buy
1,631
+286
+21% +$134K 0.01% 1107
2018
Q3 		$952K Buy
+1,345
New +$845K 0.01% 1018

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Squarepoint's SLDB Position: Q2 2026 in Review

Squarepoint sold out of Solid Biosciences (SLDB) in Q2 2026, closing a stake of 44,769 shares — an estimated $322K sold.

Squarepoint first reported a position in SLDB in Q3 2018 and held it in 12 quarters. The position peaked at $952K in Q3 2018. 156 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Squarepoint reported no remaining Solid Biosciences position as of Q2 2026 after selling out during the quarter.
  • Squarepoint sold 44,769 Solid Biosciences shares in Q2 2026, an estimated $322K.
  • Squarepoint first reported a position in Solid Biosciences in Q3 2018 and held it in 12 quarters.
  • Squarepoint's Solid Biosciences position peaked at $952K in Q3 2018.
  • 156 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.